Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

α-Methyldihydroxyphenylalanine and Release of Noradrenaline

Abstract

IT is now generally accepted that α-methyldihydroxyphenylalanine (α-methyldopa) is an effective means of lowering the blood pressure in cases of hypertension. The mechanism of its action, however, is by no means clear. One of the known actions of α-methyldopa is the inhibition of the enzyme dopadecarboxylase, and, as this enzyme is involved in the synthesis of noradrenaline, it was thought that its inhibition could explain the lowering of the blood pressure. It was found1,2 that α-methyldopa caused depletion of noradrenaline in the brain and heart, and at first this seemed to support the ideas about its hypotensive action. The duration of tissue noradrenaline depletion was, however, far greater than the duration of the dopadecarboxylase inhibition and the lowering of blood pressure. Furthermore, stronger decarboxylase inhibitors than α-methyldopa do not cause a lowering of blood pressure in hypertensive patients3. Animal experiment has shown4 that, despite noradrenaline depletion of tissues, α-methyldopa does not interfere with the effects of sympathetic nerve stimulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hess, S. M., Connamacher, R. H., Ozaki, M., and Udenfriend, S., J. Pharmacol. Exp. Therap., 134, 129 (1961).

    CAS  Google Scholar 

  2. Porter, C. C., Totaro, J. A., and Leiby, C. M., J. Pharmacol. Exp. Therap., 134, 139 (1961).

    CAS  Google Scholar 

  3. Gillespie, L., Oates, J. A., Crout, J. R., and Sjoerdsma, A., Circulation, 25, 281 (1962).

    Article  CAS  Google Scholar 

  4. Day, M. D., and Rand, M. J., Brit. J. Pharmacol., 22, 72 (1964).

    CAS  PubMed  Google Scholar 

  5. Brown, G. L., and Gillespie, J. S., J. Physiol., 138, 81 (1957).

    Article  CAS  Google Scholar 

  6. Varma, D. R., and Benfey, B. G., J. Pharmacol. Exp. Therap., 141, 310 (1963).

    CAS  Google Scholar 

  7. Stone, C. A., Ross, C. A., Wenger, H. C., Ludden, C. T., Blessing, J. A., Totaro, J. A., and Porter, C. C., J. Pharmacol. Exp. Therap., 136, 80 (1962).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

DAVIES, B. α-Methyldihydroxyphenylalanine and Release of Noradrenaline. Nature 210, 957–958 (1966). https://doi.org/10.1038/210957a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/210957a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing